DFREX
Price
$45.65
Change
-$0.40 (-0.87%)
Updated
Jun 15 closing price
Net Assets
7.11B
FSRNX
Price
$17.89
Change
-$0.14 (-0.78%)
Updated
Jun 15 closing price
Net Assets
3.13B
Interact to see
Advertisement

DFREX vs FSRNX

Header iconDFREX vs FSRNX Comparison
Open Charts DFREX vs FSRNXBanner chart's image
DFREX vs FSRNX Comparison Chart in %
View a ticker or compare two or three
VS
DFREX vs. FSRNX commentary
Jun 17, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DFREX is a Buy and FSRNX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
DFREX has more cash in the bank: 7.11B vs. FSRNX (3.14B). DFREX (2.56) and FSRNX (2.55) have matching dividends . DFREX was incepted earlier than FSRNX: DFREX (33 years) vs FSRNX (15 years). DFREX (0.21) is less costly to investors than FSRNX (0.07). FSRNX is a more actively managed with annual turnover of: 15.00 vs. DFREX (6.00). DFREX (0) and FSRNX (0) have matching initial minimum investment requirements. DFREX annual gain was more profitable for investors over the last year : 15.07 vs. FSRNX (13.88). FSRNX return over 5 years is better than : 15.01 vs. DFREX (13.35).
DFREXFSRNXDFREX / FSRNX
Total Expense Ratio0.180.07257%
Annual Report Gross Expense Ratio0.210.07300%
Fund Existence33 years15 years-
Gain YTD15.44412.346125%
Front LoadN/AN/A-
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets7.11B3.14B227%
Annual Yield % from dividends2.562.55100%
Returns for 1 year15.0713.88109%
Returns for 3 years33.4132.12104%
Returns for 5 years13.3515.0189%
Returns for 10 years70.3049.07143%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PVLA116.767.95
+7.31%
Palvella Therapeutics Inc
SRTS2.720.01
+0.37%
Sensus Healthcare
ALDFU10.82N/A
N/A
Aldel Financial II Inc
AVIR4.34-0.16
-3.45%
Atea Pharmaceuticals
SSL11.39-1.61
-12.38%
Sasol Limited